Termin realizacji zamówienia: ok. 16-18 dni roboczych.
Darmowa dostawa!
Aberrant expression and function of microRNAs (miRNAs) in cancer have added a new layer of complexity to the understanding of development and progression of the disease state.
Part I MicroRNAs: biology and implications in cancer
1 MicroRNAs and cancer: an overview Sadegh Babashah
2 Epigenetics and microRNA in cancer Jiazeng Xia, Xiaoqiang Guo, Kaiyuan Deng
3 MicroRNA, diet and cancer chemoprevention Sharanjot Saini, Rajvir Dahiya
4 MicroRNAs and energy metabolism in cancer cells Linchong Sun, Xiaoping He, Yang Cao, Ping Gao, Huafeng Zhang
5 MicroRNAs and solid tumors Gianpiero Di Leva, Michela Garofalo
6 MicroRNAs and blood cancers Charles H Lawrie
7 MicroRNAs and oncogenic human viruses Muriel Thirion, Teru Kanda, Yoshiki Murakami, Takahiro Ochiya, Hisashi Iizasa
8 MicroRNAs linking cancer and inflammation: focus on liver cancer Angélique Gougelet and Sabine Colnot
9 MicroRNAs and regulatory pathways in tumorigenesis Jun Wei, Yong Li, Xiaoming Liu, William C. Cho
10 MicroRNA-modulated apoptotic and autophagic signaling networks in cancer Bo Liu, Yu-quan Wei
11 MicroRNAs and cancer drug resistance and drug sensitivity Hugo Seca, Raquel T. Lima, M. Helena Vasconcelos
12 The biological roles of microRNAs in cancer stem cells Bin Bao, Asfar S. Azmi, Aamir Ahmad, Yiwei Li, Sanjeev Banerjee, Dejuan Kong, Shadan Ali, and Fazlul H. Sarkar
Part II MicroRNAs and their clinical implications
13 MicroRNAs and clinical implications in cancer Jürgen Wittmann
14 MicroRNA expression profiling and its clinical impact in breast cancer Manuela Ferracin, Laura Lupini
15 MicroRNAs and their clinical impact on resistance to anticancer treatment Kirsten Lindner, Joerg Haier, Richard Hummel
16 Nanocarriers and microRNA-based scenarios for cancer therapy Babak Bakhshinejad, Mohammad Amin Javidi, Sahar Babashah, Sadegh Babashah
17 Challenges and strategies for pulmonary delivery of microRNA-based therapeutics Yu Fujita, Kazuyoshi Kuwano ,Takahiro Ochiya
Abbreviations
Index
Aberrant expression and function of microRNAs (miRNAs) in cancer have added a new layer of complexity to the understanding of development and progression of the disease state. It has been demonstrated that miRNAs play a momentous role in oncogenesis via regulating cell proliferation and apoptosis as oncogenes or tumour suppressors. Expression signatures of miRNAs offer exciting opportunities for crafting cutting edge strategies in the diagnosis, prognosis, and therapy of cancer. Since miRNAs can function as either oncogenes or tumor suppressor genes in the tortuous route of oncogenesis, the promise represented by using these small RNAs as therapeutic targets presents new perspectives to the landscape of cancer therapy by either inhibiting or augmenting their activity. This book devotes efforts to provide a broad framework for obtaining an in depth understanding of the state-of-the-art knowledge on abnormalities of miRNAs found to be associated with cancer pathogenesis and possible mechanisms underlying the substantial roles played by miRNAs in cancer development and progression. Also, it intends to pave the way for readers to gain novel insights into using miRNAs as cancer biomarkers and therapeutic platforms.